PEPFAR and AstraZeneca launch partnership across HIV and hypertension services in Africa
The U.S. President's Emergency Plan for AIDS Relief (PEPFAR) and biopharmaceutical company AstraZeneca have announced a $10 million (subject to the availability of funds), five-year global public-private partnership that will expand access to HIV/AIDS and hypertension services by offering them in an integrated manner at existing PEPFAR-supported HIV/AIDS sites, beginning in Kenya.
Click on this link for more information.
